Frontlight ResearchEarly access
Congenital heart disease trials in Portugal
1 trial · From EU CTIS (euclinicaltrials.eu), checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 3Not yet taking people in PortugalCangrelor safety and pharmacodynamics in paediatric subjects with congenital heart disease
- Where
- Carnaxide
- Age
- Up to 17 years
- People
- 60 worldwide
- Run by
- Chiesi Farmaceutici S.p.A.
See details and how to join2025-523109-14-00